Aster DM Healthcare (ASTERDM.BO) Earnings Analysis
Aster DM Healthcare (ASTERDM.BO) next reports earnings on 2026-08-18, consensus EPS 2.3 INR. Last quarter (2026-04-30) it beat with EPS 2.7 INR vs 1.6 INR est (+68.8%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E 104.40.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ASTERDM.BO next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | 2.3 INR |
| Revenue estimate | 12.47B |
ASTERDM.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 2.7 INR | 1.6 INR | +68.8% | Beat |
| 2026-01-30 | 1.1 INR | 2 INR | -45% | Miss |
| 2025-09-29 | 2.13 INR | 2.2 INR | -3.2% | Miss |
| 2025-05-20 | 2.11 INR | 1.8 INR | +17.2% | Beat |
| 2025-01-31 | 1.35 INR | 1.9 INR | -28.9% | Miss |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
ASTERDM.BO valuation and analyst view
| Trailing P/E | 104.40 |
|---|---|
| Trailing EPS | 7.532 INR |
| Price / book | 8.85 |
| Dividend yield | 0.51% |
| Market cap | 413.86B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Aster DM Healthcare (ASTERDM.BO)'s next earnings date?
Aster DM Healthcare is next scheduled to report on 2026-08-18, with a consensus EPS estimate of 2.3 INR and revenue estimate of 12.47B.
Did ASTERDM.BO beat earnings last quarter?
In its 2026-04-30 report, ASTERDM.BO posted EPS of 2.7 INR versus a 1.6 INR estimate — a beat of 68.8%.
What is ASTERDM.BO's earnings track record?
Over the last 5 reported quarters with consensus data, ASTERDM.BO beat estimates 2 times (40%).
What is ASTERDM.BO's current P/E ratio and EPS?
ASTERDM.BO trades at a trailing P/E of 104.40 on trailing EPS of 7.531858164946413 INR.
What do analysts rate ASTERDM.BO?
ASTERDM.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.